chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Limb mass, Pruritus, Rash
Clinical narrative: Leg lumps; Still feeling bad; Woke in the mid night felt itchy right foot around the ankle/rash spread to whole body; woke in the mid night felt itchy right foot around the ankle; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (woke in the mid night felt itchy right foot around the ankle), LIMB MASS (Leg lumps), FEELING ABNORMAL (Still feeling bad) and RASH (Woke in the mid night felt itchy right foot around the ankle/rash spread to whole body) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Meniere's disease and Dizziness. Concurrent medical conditions included Blood pressure high. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PRURITUS (woke in the mid night felt itchy right foot around the ankle) and RASH (Woke in the mid night felt itchy right foot around the ankle/rash spread to whole body). On 13-Mar-2021, the patient experienced LIMB MASS (Leg lumps) and FEELING ABNORMAL (Still feeling bad). At the time of the report, PRURITUS (woke in the mid night felt itchy right foot around the ankle) outcome was unknown and LIMB MASS (Leg lumps), FEELING ABNORMAL (Still feeling bad) and RASH (Woke in the mid night felt itchy right foot around the ankle/rash spread to whole body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient woke up in the mid night feeling itchy right foot around the ankle and rubbed with the rug. The itchiness went away and came back again in the morning. On 13-Mar-2021, in the morning, the rash spread to the whole body.  No treatment details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination complication
Clinical narrative: Unknown adverse event; 48 days after first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Unknown adverse event) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (48 days after first vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Unknown adverse event) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (48 days after first vaccine). At the time of the report, VACCINATION COMPLICATION (Unknown adverse event) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (48 days after first vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (feeling tired) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (feeling tired). At the time of the report, FATIGUE (feeling tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pigmentation disorder, Urticaria, Vaccination site swelling
Clinical narrative: hives on both feet; Spots on right arm; Huge hive on left elbow; Tiredness; Headache; Both sides of injected arm became swollen; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Huge hive on left elbow), URTICARIA (hives on both feet), PIGMENTATION DISORDER (Spots on right arm), FATIGUE (Tiredness) and HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included METFORMIN, LEVOTHYROXINE SODIUM (SYNTHROID), LOSARTAN, OMEPRAZOLE, AMLODIPINE, VITAMIN C [ASCORBIC ACID], CALCIUM and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced FATIGUE (Tiredness), HEADACHE (Headache) and VACCINATION SITE SWELLING (Both sides of injected arm became swollen). On 13-Mar-2021, the patient experienced URTICARIA (Huge hive on left elbow). 13-Mar-2021, the patient experienced PIGMENTATION DISORDER (Spots on right arm). On 14-Mar-2021, the patient experienced URTICARIA (hives on both feet). The patient was treated with PARACETAMOL (TYLENOL) on 12-Mar-2021 at an unspecified dose and frequency. At the time of the report, URTICARIA (Huge hive on left elbow) and URTICARIA (hives on both feet) was resolving and PIGMENTATION DISORDER (Spots on right arm), FATIGUE (Tiredness), HEADACHE (Headache) and VACCINATION SITE SWELLING (Both sides of injected arm became swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 16-Mar-2021, the hives were fading and getting better.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: follow-up received and added reporter information(email) On 10-Aug-2021: Follow up document received on 10 AUG 2021 contains updated reporter's name
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site mass (developed a knot like a lump under the skin) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced vaccination site mass (developed a knot like a lump under the skin). At the time of the report, vaccination site mass (developed a knot like a lump under the skin) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Muscle rigidity, Skin discolouration
Clinical narrative: yellow green discoloration below skin; firmer to the touch; A bit headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (yellow green discoloration below skin), MUSCLE RIGIDITY (firmer to the touch), HEADACHE (A bit headache) and FATIGUE (Fatigue) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012M20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), HYDROCHLOROTHIAZIDE (DIURETIC [HYDROCHLOROTHIAZIDE]) and MILK OF MAGNESIA for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SKIN DISCOLOURATION (yellow green discoloration below skin), MUSCLE RIGIDITY (firmer to the touch), HEADACHE (A bit headache) and FATIGUE (Fatigue). At the time of the report, SKIN DISCOLOURATION (yellow green discoloration below skin), MUSCLE RIGIDITY (firmer to the touch), HEADACHE (A bit headache) and FATIGUE (Fatigue) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Influenza like illness, Myalgia, Nausea
Clinical narrative: within in 8 hours, flu-like symptoms; not taking the 2nd dose; chills all during the night; extreme muscle ache, especially in the shoulder; slight fever, estimated to be 100-101 (did not take temperature); felt like he was going to throw up but didn't; overall weakness or fatigue whatever you want to call it; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (within in 8 hours, flu-like symptoms), PRODUCT DOSE OMISSION ISSUE (not taking the 2nd dose), CHILLS (chills all during the night), MYALGIA (extreme muscle ache, especially in the shoulder) and PYREXIA (slight fever, estimated to be 100-101 (did not take temperature)) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SOTALOL, ALLOPURINOL, ASA and VITAMIN D3 for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (within in 8 hours, flu-like symptoms), PRODUCT DOSE OMISSION ISSUE (not taking the 2nd dose), CHILLS (chills all during the night), MYALGIA (extreme muscle ache, especially in the shoulder), PYREXIA (slight fever, estimated to be 100-101 (did not take temperature)), NAUSEA (felt like he was going to throw up but didn't) and FATIGUE (overall weakness or fatigue whatever you want to call it). On 26-Feb-2021, INFLUENZA LIKE ILLNESS (within in 8 hours, flu-like symptoms), PRODUCT DOSE OMISSION ISSUE (not taking the 2nd dose), CHILLS (chills all during the night), MYALGIA (extreme muscle ache, especially in the shoulder), PYREXIA (slight fever, estimated to be 100-101 (did not take temperature)), NAUSEA (felt like he was going to throw up but didn't) and FATIGUE (overall weakness or fatigue whatever you want to call it) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication includes intreso 49-50 mg.  Treatment information was not provided. /unknown.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia
Clinical narrative: within in 8 hours, flu-like symptoms; not taking the 2nd dose; chills all during the night; extreme muscle ache, especially in the shoulder; slight fever, estimated to be 100-101 (did not take temperature); felt like he was going to throw up but didn't; overall weakness or fatigue whatever you want to call it; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (within in 8 hours, flu-like symptoms), PRODUCT DOSE OMISSION ISSUE (not taking the 2nd dose), CHILLS (chills all during the night), MYALGIA (extreme muscle ache, especially in the shoulder) and PYREXIA (slight fever, estimated to be 100-101 (did not take temperature)) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SOTALOL, ALLOPURINOL, ASA and VITAMIN D3 for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (within in 8 hours, flu-like symptoms), PRODUCT DOSE OMISSION ISSUE (not taking the 2nd dose), CHILLS (chills all during the night), MYALGIA (extreme muscle ache, especially in the shoulder), PYREXIA (slight fever, estimated to be 100-101 (did not take temperature)), NAUSEA (felt like he was going to throw up but didn't) and FATIGUE (overall weakness or fatigue whatever you want to call it). On 26-Feb-2021, INFLUENZA LIKE ILLNESS (within in 8 hours, flu-like symptoms), PRODUCT DOSE OMISSION ISSUE (not taking the 2nd dose), CHILLS (chills all during the night), MYALGIA (extreme muscle ache, especially in the shoulder), PYREXIA (slight fever, estimated to be 100-101 (did not take temperature)), NAUSEA (felt like he was going to throw up but didn't) and FATIGUE (overall weakness or fatigue whatever you want to call it) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication includes intreso 49-50 mg.  Treatment information was not provided. /unknown.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: Anxiety; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced ANXIETY (Anxiety). At the time of the report, ANXIETY (Anxiety) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had stopped taking few doses of Zoloft as he was concerned the medication might reduce the response of vaccine. No treatment medication information was provided
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: very sleepy; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (very sleepy) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced SOMNOLENCE (very sleepy). At the time of the report, SOMNOLENCE (very sleepy) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Urticaria
Clinical narrative: hives chest/stomach/back; severe bodyaches; fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives chest/stomach/back), MYALGIA (severe bodyaches) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives chest/stomach/back), MYALGIA (severe bodyaches) and PYREXIA (fever). At the time of the report, URTICARIA (hives chest/stomach/back), MYALGIA (severe bodyaches) and PYREXIA (fever) outcome was unknown.            Action taken with mRNA-1273 in response to the drug was not applicable. No relevant concomitant medications were provided. No treatment was received by the patient.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Nasal congestion, Pruritus
Clinical narrative: Itching in the rest of the body; thinks she had an allergic reaction; stuffy nose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching in the rest of the body), HYPERSENSITIVITY (thinks she had an allergic reaction) and NASAL CONGESTION (stuffy nose) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PRURITUS (Itching in the rest of the body), HYPERSENSITIVITY (thinks she had an allergic reaction) and NASAL CONGESTION (stuffy nose). At the time of the report, PRURITUS (Itching in the rest of the body), HYPERSENSITIVITY (thinks she had an allergic reaction) and NASAL CONGESTION (stuffy nose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  Treatment information includes Benadryl was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site rash, Peripheral swelling, Vaccination site warmth
Clinical narrative: Hot at the site of injection; Rash on arm at site of injection; Red arm; Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE WARMTH (Hot at the site of injection) and INJECTION SITE RASH (Rash on arm at site of injection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 16M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS (history of allergy) and Autoimmune disorder NOS (Couple of auto-immune diseases). Concomitant products included RIVAROXABAN (XARELTO), CITALOPRAM, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), MULTIVITAMINS [VITAMINS NOS], FISH OIL, PROBIOTICS NOS, CALCIUM and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen arm) and INJECTION SITE RASH (Rash on arm at site of injection). On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot at the site of injection). The patient was treated with CEPHALEXIN [CEFALEXIN] at a dose of 500 mg three times a day. At the time of the report, ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen arm), VACCINATION SITE WARMTH (Hot at the site of injection) and INJECTION SITE RASH (Rash on arm at site of injection) outcome was unknown.            The action taken for mRNA-1273 was not applicable.   This case was linked to MOD21-055164 (E2B Linked Report).; Sender's Comments:  MOD21-055164:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Vaccination site induration
Clinical narrative: injection site is hard; Arm redness; arm started swelling; arm started itching; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm redness), PERIPHERAL SWELLING (arm started swelling), PRURITUS (arm started itching) and VACCINATION SITE INDURATION (injection site is hard) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced ERYTHEMA (Arm redness), PERIPHERAL SWELLING (arm started swelling) and PRURITUS (arm started itching). On an unknown date, the patient experienced VACCINATION SITE INDURATION (injection site is hard). At the time of the report, ERYTHEMA (Arm redness), PERIPHERAL SWELLING (arm started swelling), PRURITUS (arm started itching) and VACCINATION SITE INDURATION (injection site is hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment medication reported. Patient received the second vaccination in her left arm shoulder deltoid muscle.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Mass, Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MASS (She has a red clump), PRURITUS (Her left arm got itchy) and ERYTHEMA (Her left arm got red) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MASS (She has a red clump), PRURITUS (Her left arm got itchy) and ERYTHEMA (Her left arm got red). At the time of the report, MASS (She has a red clump), PRURITUS (Her left arm got itchy) and ERYTHEMA (Her left arm got red) outcome was unknown. Concomitant medication list was not reported. Treatment information was not reported
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot
Clinical narrative: arm is hot to touch; A spontaneous report was received from a consumer concerning a 92 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm is hot to touch/feeling hot.  The patient's medical history was not reported. Concomitant product use was not provided by the reporter.   The patient received their second of two planned doses of mRNA-1273 (Batch number: 010MZ0A) on 12 Mar 2021 intramuscularly in the unknown injection site for prophylaxis of COVID-19 infection.    The patient received the second dose of Moderna COVID-19 vaccine on 12 Mar 2021. The patients report that the arm is hot to touch. Treatment information of the events was not provided.   Action taken with mRNA-1273 in response to the event(s) was not provided.  The outcome of the arm is hot to touch was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received first dose of Moderna vaccine at 17 years old.) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received first dose of Moderna vaccine at 17 years old.). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (received first dose of Moderna vaccine at 17 years old.) had resolved.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old male) for mRNA-1273 (lot number unknown) with no associated AEs reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash pruritic
Clinical narrative: Extreme soreness in both upper arms; Itchy rash in abdomen , both arm and both elbows; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Extreme soreness in both upper arms) and RASH PRURITIC (Itchy rash in abdomen , both arm and both elbows) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Extreme soreness in both upper arms) and RASH PRURITIC (Itchy rash in abdomen , both arm and both elbows). At the time of the report, PAIN IN EXTREMITY (Extreme soreness in both upper arms) and RASH PRURITIC (Itchy rash in abdomen , both arm and both elbows) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not reported. The treatment information was not provided. Company comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up document was received and had non significant information.Added reporter's contact information. On 06-Aug-2021: The follow up document was received and had significant information. Updated the Date of birth of the patient; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21a) for COVID-19 vaccination.     Concurrent medical conditions included COPD and High cholesterol. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The wife is in inhaler which has steroid in it .   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: TCR attached: Provided email address
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Pain in extremity
Clinical narrative: arm was sore/felt achy; hives got worse after second dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY and CONDITION AGGRAVATED (hives got worse after second dose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011A21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, VITAMIN D3 and BIOTIN for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY and CONDITION AGGRAVATED (hives got worse after second dose). The patient was treated with ZYRTEC at an unspecified dose and frequency; HYDROXYZINE at a dose of 25 milligram and METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY and CONDITION AGGRAVATED (hives got worse after second dose) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Disturbance in attention, Emotional disorder, Insomnia
Clinical narrative: Unable to concentrate; Emotional mental problems; She cannot sleep.; Haven´t have appetite; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DISTURBANCE IN ATTENTION (Unable to concentrate), EMOTIONAL DISORDER (Emotional mental problems), INSOMNIA (She cannot sleep.) and DECREASED APPETITE (Haven´t have appetite) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Mental disorder since an unknown date. Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for Muscle spasms.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISTURBANCE IN ATTENTION (Unable to concentrate), EMOTIONAL DISORDER (Emotional mental problems), INSOMNIA (She cannot sleep.) and DECREASED APPETITE (Haven´t have appetite). At the time of the report, DISTURBANCE IN ATTENTION (Unable to concentrate), EMOTIONAL DISORDER (Emotional mental problems), INSOMNIA (She cannot sleep.) and DECREASED APPETITE (Haven´t have appetite) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Very limited information regarding these events has been provided at this time.  Prior history of mental disorder may have been contributory for the occurrence of the events. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time.  Prior history of mental disorder may have been contributory for the occurrence of the events. Further information has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain behind her right knee and the rest of the leg; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (pain behind her right knee and the rest of the leg) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain behind her right knee and the rest of the leg). On 17-Feb-2021, PAIN IN EXTREMITY (pain behind her right knee and the rest of the leg) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: hard; Fever; Fatigue; Swelling arm of injection; Red; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE INDURATION (hard), PYREXIA (Fever), FATIGUE (Fatigue), VACCINATION SITE SWELLING (Swelling arm of injection) and VACCINATION SITE ERYTHEMA (Red) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 025J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE INDURATION (hard), PYREXIA (Fever), FATIGUE (Fatigue), VACCINATION SITE SWELLING (Swelling arm of injection) and VACCINATION SITE ERYTHEMA (Red). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Feb-2021, PYREXIA (Fever) and FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE INDURATION (hard), VACCINATION SITE SWELLING (Swelling arm of injection) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), PROGESTERONE from an unknown date to 08-Feb-2021, ESTRADIOL (ESTROGEN) from an unknown date to 08-Feb-2021 and VITAMINS NOS for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 27-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On 27-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: dull headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (dull headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced HEADACHE (dull headache). At the time of the report, HEADACHE (dull headache) outcome was unknown.            No Concomitant medication was available. No Treatment Medication was available.  Action taken with mRNA-1273 in response to events were Not Applicable.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Breaking out in what appears to be shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Breaking out in what appears to be shingles) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced HERPES ZOSTER (Breaking out in what appears to be shingles). At the time of the report, HERPES ZOSTER (Breaking out in what appears to be shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: redness and itching around the injection site; additional redness and swelling.; hand pain; redness and itching around the injection site; little rash and itching at the injection site.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (hand pain), VACCINATION SITE PRURITUS (redness and itching around the injection site), VACCINATION SITE ERYTHEMA (redness and itching around the injection site), VACCINATION SITE RASH (little rash and itching at the injection site.) and VACCINATION SITE SWELLING (additional redness and swelling.) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (redness and itching around the injection site) and VACCINATION SITE RASH (little rash and itching at the injection site.). On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (hand pain). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness and itching around the injection site) and VACCINATION SITE SWELLING (additional redness and swelling.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at a dose of 1 dosage form and IBUPROFEN for Pain relief, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (hand pain), VACCINATION SITE PRURITUS (redness and itching around the injection site), VACCINATION SITE ERYTHEMA (redness and itching around the injection site), VACCINATION SITE RASH (little rash and itching at the injection site.) and VACCINATION SITE SWELLING (additional redness and swelling.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Somnolence
Clinical narrative: Is sleepy; chills; muscle aches; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Is sleepy), CHILLS (chills), MYALGIA (muscle aches) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced SOMNOLENCE (Is sleepy), CHILLS (chills), MYALGIA (muscle aches) and FATIGUE (fatigue). At the time of the report, SOMNOLENCE (Is sleepy), CHILLS (chills), MYALGIA (muscle aches) and FATIGUE (fatigue) outcome was unknown.            No treatment information was reported. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 87.0
Sex: U
Vaccine: COVID19
Symptoms: Delayed sleep phase, Insomnia, Limb discomfort
Clinical narrative: delayed sleep; could not sleep in the whole night; Light discomfort in the arm; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep in the whole night), LIMB DISCOMFORT (Light discomfort in the arm) and DELAYED SLEEP PHASE (delayed sleep) in an 87-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hernia.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced INSOMNIA (could not sleep in the whole night) and LIMB DISCOMFORT (Light discomfort in the arm). On an unknown date, the patient experienced DELAYED SLEEP PHASE (delayed sleep). At the time of the report, INSOMNIA (could not sleep in the whole night) and LIMB DISCOMFORT (Light discomfort in the arm) had not resolved and DELAYED SLEEP PHASE (delayed sleep) outcome was unknown.            patient have blood thinners.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Headache, Pain in extremity
Clinical narrative: Heated arm; A little red spot, quarter-spot; Arm hurt; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Heated arm), ERYTHEMA (A little red spot, quarter-spot), PAIN IN EXTREMITY (Arm hurt) and HEADACHE (Slight headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062G20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Heated arm), ERYTHEMA (A little red spot, quarter-spot), PAIN IN EXTREMITY (Arm hurt) and HEADACHE (Slight headache). At the time of the report, FEELING HOT (Heated arm), ERYTHEMA (A little red spot, quarter-spot) and PAIN IN EXTREMITY (Arm hurt) outcome was unknown and HEADACHE (Slight headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment medication was reported.   This case was linked to MOD-2021-047157 (E2B Linked Report). This case was linked to MOD-2021-047157 (Patient Link).; Sender's Comments:  MOD-2021-047157:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Nausea, Oropharyngeal discomfort, Pain
Clinical narrative: Pain from the neck down to the body; Throat is feeling stuffed; swallowing discomfort due to throat irritation; Pain at injection site; Muscle and Joint pain; Muscle and Joint pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain from the neck down to the body), OROPHARYNGEAL DISCOMFORT (Throat is feeling stuffed), THROAT IRRITATION (swallowing discomfort due to throat irritation), VACCINATION SITE PAIN (Pain at injection site) and MYALGIA (Muscle and Joint pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis and Heart disease, unspecified (heart disease). Concomitant products included METOPROLOL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), SIMVASTATIN and VITAMIN D3 for an unknown indication.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN (Pain from the neck down to the body), OROPHARYNGEAL DISCOMFORT (Throat is feeling stuffed), THROAT IRRITATION (swallowing discomfort due to throat irritation), VACCINATION SITE PAIN (Pain at injection site), MYALGIA (Muscle and Joint pain), ARTHRALGIA (Muscle and Joint pain) and NAUSEA (Nausea). On 16-Mar-2021, PAIN (Pain from the neck down to the body), OROPHARYNGEAL DISCOMFORT (Throat is feeling stuffed), THROAT IRRITATION (swallowing discomfort due to throat irritation), VACCINATION SITE PAIN (Pain at injection site), MYALGIA (Muscle and Joint pain), ARTHRALGIA (Muscle and Joint pain) and NAUSEA (Nausea) had resolved.            Concomitant medications included unspecified dietary supplement and chewable vitamins.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Significant follow up-outcome of the events updated
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation, Vaccination site pain
Clinical narrative: Pain from the neck down to the body; Throat is feeling stuffed; swallowing discomfort due to throat irritation; Pain at injection site; Muscle and Joint pain; Muscle and Joint pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain from the neck down to the body), OROPHARYNGEAL DISCOMFORT (Throat is feeling stuffed), THROAT IRRITATION (swallowing discomfort due to throat irritation), VACCINATION SITE PAIN (Pain at injection site) and MYALGIA (Muscle and Joint pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis and Heart disease, unspecified (heart disease). Concomitant products included METOPROLOL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), SIMVASTATIN and VITAMIN D3 for an unknown indication.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN (Pain from the neck down to the body), OROPHARYNGEAL DISCOMFORT (Throat is feeling stuffed), THROAT IRRITATION (swallowing discomfort due to throat irritation), VACCINATION SITE PAIN (Pain at injection site), MYALGIA (Muscle and Joint pain), ARTHRALGIA (Muscle and Joint pain) and NAUSEA (Nausea). On 16-Mar-2021, PAIN (Pain from the neck down to the body), OROPHARYNGEAL DISCOMFORT (Throat is feeling stuffed), THROAT IRRITATION (swallowing discomfort due to throat irritation), VACCINATION SITE PAIN (Pain at injection site), MYALGIA (Muscle and Joint pain), ARTHRALGIA (Muscle and Joint pain) and NAUSEA (Nausea) had resolved.            Concomitant medications included unspecified dietary supplement and chewable vitamins.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Significant follow up-outcome of the events updated
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. An autopsy was performed.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-043354 (Patient Link).   Reporter did not allow further contact